Robust Capillary- and Micro-Flow Liquid Chromatography-Tandem Mass Spectrometry Methods for High-Throughput Proteome Profiling. 2022

Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
Department of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.

Capillary- and micro-flow liquid chromatography-tandem mass spectrometry (capLC-MS/MS and μLC-MS/MS) is becoming a valuable alternative to nano-flow LC-MS/MS due to its high robustness and throughput. The systematic comparison of capLC-MS/MS and μLC-MS/MS systems for global proteome profiling has not been reported yet. Here, the capLC-MS/MS (150 μm i.d. column, 1 μL/min) and μLC-MS/MS (1 mm i.d. column, 50 μL/min) systems were both established based on UltiMate 3000 RSLCnano coupled to an Orbitrap Exploris 240 by integrating with different flowmeters. We evaluated both systems in terms of sensitivity, analysis throughput, separation efficiency, and robustness. capLC-MS/MS was about 10 times more sensitive than μLC-MS/MS at different gradient lengths. Compared with capLC-MS/MS, μLC-MS/MS was able to achieve higher analysis throughput and separation efficiency. During the 7 days' long-term performance test, both systems showed good reproducibility of chromatographic full width (RSD < 3%), retention time (RSD < 0.4%), and protein identification (RSD < 3%). These results demonstrate that capLC-MS/MS is more suitable for high-throughput analysis of clinical samples with a limited starting material. When enough samples are available, μLC-MS/MS is preferred. Together, capLC and μLC coupled to Orbitrap Exploris 240 with moderate sensitivity should well meet the needs of large-cohort clinical proteomic analysis.

UI MeSH Term Description Entries
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem
D020543 Proteome The protein complement of an organism coded for by its genome. Proteomes
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
January 2000, Rapid communications in mass spectrometry : RCM,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
July 1995, Journal of the American Society for Mass Spectrometry,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
October 2015, Rapid communications in mass spectrometry : RCM,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
April 2013, Drug research,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
January 2011, Clinica chimica acta; international journal of clinical chemistry,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
June 2012, Journal of chromatography. A,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
April 2005, Molecular & cellular proteomics : MCP,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
April 2008, Electrophoresis,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
August 2020, Journal of visualized experiments : JoVE,
Xintong Sui, and Qiong Wu, and Xiaozhen Cui, and Xi Wang, and Luobin Zhang, and Nan Deng, and Yangyang Bian, and Ruilian Xu, and Ruijun Tian
October 2006, Analytica chimica acta,
Copied contents to your clipboard!